John D. Halpern - Significant Ownership

Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by John D. Halpern.

Significant Ownership of John D. Halpern

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ERNA	Eterna Therapeutics Inc.	Common Stock, par value $0.005 per share	9.6%	$1.25M	$175K	5.97M	+16.3%	John D. Halpern	Mar 31, 2025

Showing 1 to 1 of 1 entries

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.